Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey M Switchenko

Showing results (31-40 of 181) with videos related to

Pageof 19
Sort By:
Journal of Pediatric Hematology/Oncology|September 20, 2014
Outcomes After Radiation Therapy to Metastatic Sites in Patients With Stage 4 NeuroblastomaShravan Kandula, Roshan S Prabhu, Ronica Nanda, et al.
Journal of the American College of Radiology : JACR|March 23, 2017
Breast Cancer Screening in Patients With Newly Diagnosed Lung and Colorectal Cancer: A Population-Based Study of UtilizationGelareh Sadigh, Ruth C Carlos, Kevin C Ward, et al.
Radiation Oncology (London, England)|March 5, 2013
Breast reconstruction and post-mastectomy radiation practiceSusie A Chen, Crispin Hiley, Dana Nickleach, et al.
Journal of the American College of Radiology : JACR|July 19, 2021
Racial Disparities in Diagnostic Delay Among Women With Breast CancerJasmine M Miller-Kleinhenz, Lindsay J Collin, Rebecca Seidel, et al.
Prostate Cancer and Prostatic Diseases|November 14, 2020
Stereotactic body radiation therapy use for high risk prostate cancer in the United StatesSagar A Patel, Jeffrey M Switchenko, Amar U Kishan, et al.
Frontiers in Oncology|January 11, 2014
Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast CancerDavid M Marcus, Jeffrey M Switchenko, Roshan Prabhu, et al.
International Journal of Breast Cancer|August 13, 2015
Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation TherapyShravan Kandula, Jeffrey M Switchenko, Saul Harari, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 25, 2020
Maintenance Therapy for Cutaneous T-cell Lymphoma After Total Skin Electron Irradiation: Evidence for Improved Overall Survival With Ultraviolet TherapyMatthew R Kudelka, Jeffrey M Switchenko, Mary Jo Lechowicz, et al.
Journal of Surgical Oncology|January 9, 2023
Outcomes of the same-day discharge following mastectomy before, during and after COVID-19 pandemicYuliya Olimpiadi, Alison R Goldenberg, Lauren Postlewait, et al.
European Urology Oncology|July 7, 2020
Low Utilization of Androgen Deprivation Therapy Among Men Receiving Stereotactic Body Radiotherapy for Localized Prostate Cancer in the United StatesTrevor J Royce, Jeffrey M Switchenko, Chao Zhang, et al.
Pageof 19

Showing results (31-40 of 181) with videos related to

Sort By:
Pageof 19
Journal of Pediatric Hematology/Oncology|September 20, 2014
Outcomes After Radiation Therapy to Metastatic Sites in Patients With Stage 4 NeuroblastomaShravan Kandula, Roshan S Prabhu, Ronica Nanda, et al.
Journal of the American College of Radiology : JACR|March 23, 2017
Breast Cancer Screening in Patients With Newly Diagnosed Lung and Colorectal Cancer: A Population-Based Study of UtilizationGelareh Sadigh, Ruth C Carlos, Kevin C Ward, et al.
Radiation Oncology (London, England)|March 5, 2013
Breast reconstruction and post-mastectomy radiation practiceSusie A Chen, Crispin Hiley, Dana Nickleach, et al.
Journal of the American College of Radiology : JACR|July 19, 2021
Racial Disparities in Diagnostic Delay Among Women With Breast CancerJasmine M Miller-Kleinhenz, Lindsay J Collin, Rebecca Seidel, et al.
Prostate Cancer and Prostatic Diseases|November 14, 2020
Stereotactic body radiation therapy use for high risk prostate cancer in the United StatesSagar A Patel, Jeffrey M Switchenko, Amar U Kishan, et al.
Frontiers in Oncology|January 11, 2014
Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast CancerDavid M Marcus, Jeffrey M Switchenko, Roshan Prabhu, et al.
International Journal of Breast Cancer|August 13, 2015
Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation TherapyShravan Kandula, Jeffrey M Switchenko, Saul Harari, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 25, 2020
Maintenance Therapy for Cutaneous T-cell Lymphoma After Total Skin Electron Irradiation: Evidence for Improved Overall Survival With Ultraviolet TherapyMatthew R Kudelka, Jeffrey M Switchenko, Mary Jo Lechowicz, et al.
Journal of Surgical Oncology|January 9, 2023
Outcomes of the same-day discharge following mastectomy before, during and after COVID-19 pandemicYuliya Olimpiadi, Alison R Goldenberg, Lauren Postlewait, et al.
European Urology Oncology|July 7, 2020
Low Utilization of Androgen Deprivation Therapy Among Men Receiving Stereotactic Body Radiotherapy for Localized Prostate Cancer in the United StatesTrevor J Royce, Jeffrey M Switchenko, Chao Zhang, et al.
Pageof 19